This Presolicitation opportunity from Department Of Veterans Affairs was posted on January 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6505--Notice of Intent to Sole Source F-18 Piflufolastat (Pylarify for the George E. Wahlen VA Medical Center in Salt Lake City, Utah.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
General Info
Place of Performance
COSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatSign up to view the full breakdown with detailed analysis of each section.
View Full BreakdownThis one is closed. Find the next one like it.
Open contracts like this one, right now:
- Compounded Antimicrobial Homecare Supply and ServiceOpen now, due in 3 days
- Compounded Desferrioxamine Homecare Supply and ServiceOpen now, due in 3 days
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Submission Closed
Organization & Contact Information
Full Description
THIS IS NOT A SOLICITATION OR REQUEST FOR OFFERS. NO SOLICITATION PACKAGE IS AVAILABLE NOR WILL TELEPHONE REQUESTS BE HONORED. NO SOLICITATION WILL BE POSTED TO CONTRACT OPPORTUNITIES.
PROCUREMENT TITLE: Pylarify Radiopharmaceuticals INTENT TO AWARD: The Department of Veterans Affairs (NCO 19), 6162 S. Willow Drive, Greenwood Village, CO 80111, intends to award one (1) task order on a sole source basis, to Progenics Pharmaceuticals, Inc., for PYLARIFY® (piflufolastat F 18) Injections.
BACKGROUND AND DESCRIPTION: This procurement is for the continued providing of unit dose syringes of F-18 Piflufolastat (Pylarify) for positron emitting tomography (PET) imaging as ordered by the Nuclear Medicine Department. Pylarify is a radiopharmaceutical, or medicinal radio-compound, and contains radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to diagnose specific pathologies, such as cancer, osteomyelitis, cardiac ischemia, and infection. NAICS: 325412 Pharmaceutical Preparation Manufacturing, $34 Million
PSC: 6505 Drugs and Biologicals
AUTHORITY: This procurement will be issued under the authority of FAR Part 8 Required Sources of Supplies and Services. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Contracting Officer.
INTERESTED PARTIES: THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement as described in the attached Statement of Work no later than 3:00 PM Mountain Standard Time, Wednesday, February 4th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to Sign up to see this detail.
A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice.
ATTACHED: Statement of Work
More opportunities from Department Of Veterans Affairs → Network Contract Office 19 (36C259)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
